Zepbound has been shown to produce around 20% body weight loss in clinical settings
The consequences extend beyond slowed weight loss
If youre prescribed an injectable form of semaglutide, make sure youre instructed on proper dosing, sterile technique, and needle disposal to reduce risks of infection or dosing errors
Zepbound stands out because it targets two key gut hormonesGLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide)
Adverse events such as diarrhea, constipation, nausea, and vomiting associated with the GLP-1 RAs overlap with those seen with cancer treatments, so the patient who is undergoing treatment with an emetogenic regimen for cancer will likely experience additional weight loss, which can lead to nutritional deficiencies, loss of lean muscle mass, and loss of bone mass
For those seeking weight management support now, approved options in the UK include: Orlistat available on NHS prescription and over the counter